Advertisement ยท 728 ร— 90

Posts by

Post image

The big reveal starts. #escmidglobal

1 year ago 6 0 0 0
Post image

Following up, Gunnar also shows the problems with the screening tests. It's a challenge in high R area #escmidglobal #escmid2025

1 year ago 1 0 0 0

Totally agree, not sure why it's that relevant.... (Or we could just repeat the test?)

1 year ago 2 0 0 0
Post image

Gunnar from EUCAST talking about the complexities of susceptibility testing using oxacillin disc screening. #escmid2025

1 year ago 1 0 0 0

It zero shots stuff in R, complex plots with in built linear models, saves to a pdf, everything works. Incredible for simulations.

1 year ago 0 0 0 0
Post image

NEW PREPRINT!

Enjoyed working with @tom-parks.bsky.social and @petedodd24.bsky.social on immortal time bias

In its simplest form, ITB results from misallocation of person time, i.e. pre treatment time in intervention group being counted as time on treatment

www.medrxiv.org/content/10.1...

[1/n]

1 year ago 55 23 10 2

Ah thanks I should have done this!

1 year ago 1 0 0 0
Advertisement
Post image Post image

We are looking for patient, clinician and researcher insight into priorities for community acquired pneumonia!

This is a JLA Priority Setting Partnership and will drive the UK research agenda for years to come - please share!!

โ›„๐ŸŽ„โ›„๐ŸŽ„!!

forms.office.com/Pages/Respon...

1 year ago 2 2 1 0

Just a short piece on FQ prescribing. Basically, it's gone downhill, in relation to comparator antibiotics and absolutely. Still waiting for the MHRA to release the report with new information...

1 year ago 4 2 1 0
DEFINE_ME

NEW LETTER! Me and @gushamilton.bsky.social argue that, if you want to demonstrate all oral treatment for pneumonia is adequate, then systematically excluding from sample people who are switched to IV after failing oral therapy is problematic

www.clinicalmicrobiologyandinfection.com/article/S119...

1 year ago 18 4 2 3

No... But they offer a great service generally!

1 year ago 3 0 0 0

Just really cool.

1 year ago 3 0 0 0

What an absolutely lovely paper. Important topic. I wonder what it would cost today and how much the total cost was. Such a lovely bit of work. Will keep this for talks and presentations.

1 year ago 2 0 0 0

As in, we think shorter is better. So why would there be increased harm with a day less antibiotics? I just can't really square it with e.g. balance. And the CRP arm mortality was about the same as PCT arm. I think it's just small numbers.

1 year ago 2 0 1 0

I thought about this but I think it's just a bit too imprecise and I think the mechanism for increased mortality is not really there. So I *think* we are just seeing noise.

1 year ago 3 0 1 0

regardless, a very, very impressive trial and well run. Congrats to all authors! @darknatter.bsky.social

1 year ago 3 0 0 0

I don't think you can easily claim that PCT reduces abx use but that the mortality is the same. It's just too imprecise to call mortality. We can't infer much about the effect on mortality. I am not sure the NI margin is what patients/clinicians would accept.

1 year ago 2 0 1 0
Advertisement
Preview
Biomarker-Guided Antibiotic Duration for Patients With Suspected Sepsis This clinical trial assessed whether treatment protocols for monitoring C-reactive protein or procalcitonin safely reduced the amount of time critically ill adults with suspected sepsis received antib...

Interesting trial. If we took the point estimates, then we would accept 0.9 days less abx per person, for a 1.6% absolute mortality increase. Not sure I would take that. Obviously, imprecision means both of these are less precise; but I think not a clear 'win' for PCT
jamanetwork.com/journals/jam...

1 year ago 6 1 2 0

I saw one just this week! If only you'd published it last week...

1 year ago 1 0 0 0

Don't
I've got too much to do

1 year ago 2 0 0 0

I definitely think this is underexplored. lots of appropriate datasets in which to study this. Very interesting!

1 year ago 1 0 0 0

Colin, wouldn't one analysis compare different ages as we know drinking has reduced in younger people. So if we see larger effects in younger folk makes less likely to be alcohol related.

1 year ago 0 0 1 0

This is lovely work Paul. Lovely. We are just thinking about in vitro systems and phages and how to start testing this systematically. Such interesting data. Thanks for sharing.

1 year ago 1 0 1 0

This must be in party diagnosis of fatty liver and increased use of e.g. fibroscans that pick up these. But not a hematologist or an epidemiologist. But I can't quite tie it together.

1 year ago 0 0 0 0

And what a paper to choose ;)

1 year ago 1 0 0 0
Advertisement

Not gonna disagree with a Nobel prize winner on the economics here, but people underestimate Trump and the power being crazy has. If people think he will do something crazy, they change their behaviour in funny ways(and sometimes in his favour). I don't think it's a rational play, that's the point.

1 year ago 0 0 1 0

Yes I meant to do tom too then fat fingered and not used to blue sky!

1 year ago 1 0 1 0

Although I suppose cough is biology ๐Ÿคฃ

1 year ago 0 0 1 0

What's the best book for understanding LLMs and their ilk? I understand basic statistics and computing (i.e. I can use bash, python, and HPC clusters). So something that works from there upwards. Like explains transformers.

1 year ago 0 0 0 0

Oh and I would love to see more about the smoking association. MVMR would seem super interesting here. Lots to think about. I always wonder about increased diagnosis in smokers due to cough as well as actual biology. Can't wait to see new preprint!

1 year ago 2 0 1 0